Neuropathology of synuclein aggregates: New insights into mechanisms of neurodegenerative diseases

Journal of Neuroscience Research

Volumn 61, Issue 2, 2000, Pages 121-127

  Duda, John E ^a   Lee, Virginia M Y ^a   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

synuclein; Alzheimer's disease; Dementia with Lewy bodies; Multiple system atrophy; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PROTEIN; BRAIN PROTEIN; IRON;

ALZHEIMER DISEASE; BRAIN DEGENERATION; DEGENERATIVE DISEASE; DEMENTIA; HUMAN; LEWY BODY; MISSENSE MUTATION; NEUROPATHOLOGY; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY;

ALPHA-SYNUCLEIN; ANIMALS; GAMMA-SYNUCLEIN; HUMANS; LEWY BODIES; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; SENILE PLAQUES; SYNUCLEINS;

EID: 0034661820     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4     Document Type: Short Survey

References (52)

1. Arai T, Ueda K, Ikeda K, Akiyama H, Haga C, Kondo H, Kuroki N, Niizato K, Iritani S, Tsuchiya K. 1999. Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/alpha-synuclein. Neurosci Lett 259:83-86.
2. Arawaka S, Saito Y, Murayama S, Mori H. 1998. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein. Neurology 51:887-889.
3. Arima K, Ueda K, Sunohara N, Hirai S, Izumiyama Y, Tonozuka-Uehara H, Kawai M. 1998a. Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 808:93-100.
4. Arima K, Ueda K, Sunohara N, Arakawa K, Hirai S, Nakamura M, Tonozuka-Uehara H, Kawai M. 1998b. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol (Berl) 96:439-444.
5. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T. 1998. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879-884.
6. Bayer TA, Jakala P, Hartmann T, Havas L, McLean C, Culvenor JG, Li QX, Masters CL, Falkai P, Beyreuther K. 1999. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores. Neurosci Lett 266:213-216.
7. Clayton DF, George JM. 1999. Synucleins in synaptic plasticity and neurodegenerative disorders. J Neurosci Res 58:120-129.
8. Conway KA, Harper JD, Lansbury PT. 1998. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 4:1318-1320.
9. Crowther RA, Jakes R, Spillantini MG, Goedert M. 1998. Synthetic filaments assembled from C-terminally truncated alpha-synuclein. FEBS Lett 436:309-312.
10. Culvenor JG, McLean CA, Cutt S, Campbell BC, Maher F, Jäkälä P, Hartmann T, Beyreuther K, Masters CL, Li QX. 1999. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited : NAC and alpha-synuclein are not associated with Abeta amyloid. Am J Pathol 155:1173-1181.
11. Davidson WS, Jonas A, Clayton DF, George JM. 1998. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273:9443-9449.
12. Dickson DW, Liu W, Hardy J, Farrer M, Mehta N, Uitti R, Mark M, Zimmerman T, Golbe L, Sage J, Sima A, D'Amato C, Albin R, Gilman S, Yen S. 1999a. Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol 155:1241-1251.
13. Dickson DW, Lin W, Liu WK, Yen SH. 1999b. Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol 9:721-732.
14. Dooling EC, Schoene WC, Richardson EP, Jr. 1974. Hallervorden-Spatz syndrome. Arch Neurol 30:70-83.
15. El Agnaf OM, Jakes R, Curran MD, Wallace A. 1998a. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease. FEBS Lett 440:67-70.
16. El Agnaf OM, Jakes R, Curran MD, Middleton D, Ingenito R, Bianchi E, Pessi A, Neill D, Wallace A. 1998b. Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett 440:71-75.
17. Gai WP, Power JH, Blumbergs PC, Blessing WW. 1998. Multiple-system atrophy: a new alpha-synuclein disease? Lancet 352:547-548.
18. Gai WP, Power JH, Blumbergs PC, Culvenor JG, Jensen PH. 1999. Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components. J Neurochem 73: 2093-2100.
19. Galvin JE, Uryu K, Lee VM, Trojanowski JQ. 1999. Axon pathology in Parkinson's disease and lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci USA 96:13450-13455.
20. Giasson BI, Uryu K, Trojanowski JQ, Lee VM. 1999. Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 274:7619-7622.
21. Han H, Weinreb PH, Lansbury PT, Jr. 1995. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem Biol 2:163-169.
22. Hashimoto M, Hsu LJ, Sisk A, Xia Y, Takeda A, Sundsmo M, Masliah E. 1998. Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res 799:301-306.
23. Hashimoto M, Hsu LJ, Xia Y, Takeda A, Sisk A, Sundsmo M, Masliah E. 1999a. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. Neuroreport 10:717-721.
24. Hashimoto M, Takeda A, Hsu LJ, Takenouchi T, Masliah E. 1999b. Role of cytochrome c as a stimulator of alpha-synuclein aggregation in lewy body disease. J Biol Chem 274:28849-28852.
25. Irizarry MC, Kim TW, McNamara M, Tanzi RE, George JM, Clayton DF, Hyman BT. 1996. Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. J Neuropathol Exp Neurol 55:889-895.
26. Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT. 1998. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol 57:334-337.
27. Iwai A, Yoshimoto M, Masliah E, Saitoh T. 1995. Non-A beta component ot Alzheimer's disease amyloid (NAC) is amyloidogenic. Biochemistry 34:10139-10145.
28. Jakes R, Crowther RA, Lee VMY, Trojanowski JQ, Iwatsubo T, Goedert M. 1999. Epitope mapping of LB509, a monoclonal antibody directed against human alpha-synuclein. Neurosci Lett 269:13-16.
29. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O. 1998. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18:106-108.
30. Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, Nee LE, O'Connell B, Pollen DA, George-Hyslop P, Ghetti B, Nochlin D, Bird TD, Cairns NJ, Lee VM, Iwatsubo T, Trojanowski JQ. 1998. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 153:1365-1370.
31. Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ. 1999. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann Neurol 45:353-357.
32. Maroteaux L, Campanelli JT, Scheller RH. 1988. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804-2815.
33. Masliah E, Iwai A, Mallory M, Ueda K, Saitoh T. 1996. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. Am J Pathol 148:201-210.
34. Mezey E, Dehejia AM, Harta G, Tresser N, Suchy SF, Nussbaum RL, Brownstein MJ, Polymeropoulos MH. 1998a. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease. Mol Psychiatry 3:493-499.
35. Mezey E, Dehejia A, Harta G, Papp MI, Polymeropoulos MH, Brownstein MJ. 1998b. Alpha synuclein in neurodegenerative disorders: murderer or accomplice? Nat Med 4:755-757.
36. Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, Anafi D, Kaufman SA, Martin F, Sitney K, Denis P, Louis JC, Wypych J, Biere AL, Citron M. 1999. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J Biol Chem 274:9843-9846.
37. Newell K, Boyer P, Gomez-Tortosa E, Hobbs W, Hedley-Whyte ET, Vonsattel JP, Hyman B. 1999. Alpha-synuclein immunoreactivity is present in axonal swellings in neuraxonal dystrophy and acute traumatic brain injury. J Neuropathol Exp Neurol 58:1263-1268.
38. Pollanen MS, Dickson DW, Bergeron C. 1993. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52:183-191.
39. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di lorio G, Golbe LI, Nussbaum RL. 1997. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047.
40. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. 1997. Alpha-synuclein in Lewy bodies. Nature 388:839-840.
41. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M. 1998. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 251:205-208.
42. Takeda A, Hashimoto M, Mallory M, Sundsumo M, Hansen L, Sisk A, Masliah E. 1998. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Lab Invest 78:1169-1177.
43. Tu PH, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, Nakajo S, Iwatsubo T, Trojanowski JQ, Lee VM. 1998. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 44:415-422.
44. Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T. 1993. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90:11282-11286.
45. Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H. 1997. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett 239:45-48.
46. Wakabayashi K, Hayashi S, Kakita A, Yamada M, Toyoshima Y, Yoshimoto M, Takahashi H. 1998a. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol (Berl) 96:445-452.
47. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. 1998b. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180-182.
48. Wakabayashi K, Yoshimoto M, Fukushima T, Koide R, Horikawa Y, Morita T, Takahashi H. 1999. Widespread occurrence of alpha-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset hallervorden-spatz disease with lewy bodies. Neuropathol Appl Neurobiol 25:363-368.
49. Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H. 2000. NACP/Alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol (Berl) 99:14-20.
50. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT, Jr. 1996. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35:13709-13715.
51. Wood SJ, Wypych J, Steavenson S, Louis JC, Citron M, Biere AL. 1999. Alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J Biol Chem 274:19509-19512.
52. Yoshimoto M, Iwai A, Kang D, Otero DA, Xia Y, Saitoh T. 1995. NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation. Proc Natl Acad Sci USA 92:9141-9145.